Arctic Diagnostics
ArcDia International Ltd is a Finnish company specializing in the development and manufacturing of high-quality diagnostic products for acute infections. With over 10 years of experience, they focus on rapid, high-throughput, and reliable tests for respiratory and gastrointestinal infections, including COVID-19, influenza, RSV, and CDI. Their flagship product, mariPOC, utilizes proprietary TPX technology for automated, multianalyte antigen detection at the point of sampling, aiming to improve healthcare processes and enable accessible professional diagnostics through pharmacies and decentralized testing.
Industries
Nr. of Employees
small (1-50)
Arctic Diagnostics
Patents
Use of two-photon excited fluorescence in assays of clinical chemistry analytes
US-10295465-B2
View DetailsTwo-photon absorbing dipyrrometheneboron difluoride dyes and their applications
US-7763439-B2
View Details
Use of two-photon excited fluorescence in assays of clinical chemistry analytes
US-10295465-B2
View DetailsTwo-photon absorbing dipyrrometheneboron difluoride dyes and their applications
US-7763439-B2
View DetailsProducts
Automated multianalyte antigen test system (bench-top)
Automated bench-top sample-to-answer analyzer that runs multianalyte sandwich immunoassays from a single clinical sample using dry-stored reagent cartridges and fluorescence microparticle readout.
Phenotypic in-well AST platform
Automated in-well culture-based AST that monitors bacterial growth via immunoassay signal in real time to determine susceptibility and species information directly from clinical samples.
Cloud-based real-time epidemiological surveillance service
Online service that aggregates device results to provide real-time infection incidence monitoring for public health and operational preparedness.
Automated multianalyte antigen test system (bench-top)
Automated bench-top sample-to-answer analyzer that runs multianalyte sandwich immunoassays from a single clinical sample using dry-stored reagent cartridges and fluorescence microparticle readout.
Phenotypic in-well AST platform
Automated in-well culture-based AST that monitors bacterial growth via immunoassay signal in real time to determine susceptibility and species information directly from clinical samples.
Cloud-based real-time epidemiological surveillance service
Online service that aggregates device results to provide real-time infection incidence monitoring for public health and operational preparedness.
Services
Licensing of the two-photon excitation assay detection platform and related intellectual property for use in infectious disease diagnostics.
Distribution and partnership support including marketing materials and product training for regional distributors.
Licensing of the two-photon excitation assay detection platform and related intellectual property for use in infectious disease diagnostics.
Distribution and partnership support including marketing materials and product training for regional distributors.
Expertise Areas
- Point-of-care multianalyte diagnostics
- Antigen assay development and validation
- Two-photon excitation fluorescence assay development
- Phenotypic antimicrobial susceptibility testing (AST)
Key Technologies
- Two-photon excitation fluorescence assay
- Sandwich immunoassay
- Microparticle solid-phase chemistry
- Separation-free one-step fluorescence assays
News & Updates
New mariPOC research results will be published at the National Virology Days in Helsinki.
ArcDia’s mariPOC team will be present and available for meetings at ECCMID2022 in Lisbon.
Come meet us at NSCMID conference 2021 in Turku.
ArcDia’s R&D director Janne O. Koskinen talk at the online conference.
ArcDia’s R&D director Janne O. Koskinen speech at the online conference.
Visit booth 1.7f at ECCMID 2019 in Amsterdam.
New mariPOC research results will be published at the National Virology Days in Helsinki.
ArcDia’s mariPOC team will be present and available for meetings at ECCMID2022 in Lisbon.
Come meet us at NSCMID conference 2021 in Turku.
ArcDia’s R&D director Janne O. Koskinen talk at the online conference.
ArcDia’s R&D director Janne O. Koskinen speech at the online conference.
Visit booth 1.7f at ECCMID 2019 in Amsterdam.